SULFOXIMINE-SUBSTITUTED PYRIMIDINES AS CDK- AND/OR VEGF INHIBITORS, THEIR PRODUCTION AND USE AS PHARMACEUTICAL AGENTS

摘要

This invention relates to pyrimidine derivatives of general formula I(see formula I)in which Q, R1, R2, R3, R4, R5, X, and m have the meanings that are containedin thedescription, as inhibitors of cyclin-dependent kinases and VEGF-receptortyrosinekinases, their production as well as their use as medications for treatment ofvariousdiseases.